A colored transmission electron micrograph (TEM) of a neuromuscular junction. (Thomas Deerinck, NCMIR / Science Source)
CAR-T cell therapy for myasthenia gravis shows promise in small study by Cartesian Therapeutics
Danny DeBerry was starting to lose hope. For more than a decade, the North Carolina forester had suffered from myasthenia gravis, a disease where a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
